Brainstem involvement in obsessive-compulsive disorder

Biological Psychology

Volumn 48, Issue 1, 1998, Pages 69-77

  Nolfe, G ^a   Serra, F P ^b   Palma, V ^c   Buscaino, G A ^b  

^a Department of Neurodynamics   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Pellegrini Hospital   (Italy)

Author keywords

Baep; Brainstem; Obsessive compulsive disorder; Serotonin

Indexed keywords

SEROTONIN;

ADULT; ANXIETY NEUROSIS; ARTICLE; BRAIN STEM; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; NEUROSIS; NORMAL HUMAN; OBSESSION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; WAVEFORM;

ADULT; ANXIETY DISORDERS; BRAIN STEM; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; NEUROTIC DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN;

EID: 0031826535     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0511(97)00032-X     Document Type: Article

References (36)

1. American Electroencephalographic Society Guidelines for Clinical Evoked Potentials Studies. J. Clin. Neurophysiol. 1:1984;3-53.
2. American Psychiatric Association, 1994. DSM-IV Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC.
3. Barr C.L., Goodman W.K., Price L.H., Price L.H., McDougle C.J., Charney D.S. The serotonin hypothesis of obsessive compulsive disorder: implication of pharmacologic challenge studies. J. Clin. Psychiatry. 53(Suppl.):1992;17-28.
4. Baxter L.R., Schwartz J.M., Mazziotta J.C., Phelps M.E., Pahl J.J., Guze B.H. Glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Biol. Psychiatry. 145:1988;1560-1563.
5. Bhargava V.K., McKean C. Role of 5-hydroxytryptamine in the modulation of acoustic brainstem (far-field) potentials. Neuropharmacology. 16:1977;447-449.
6. Bhargava V.K., Salamy Y., McKean C. Effect of cholinergic drugs on the brainstem auditory evoked responses (far-field) in rats. Neuroscience. 3:1978;821-826.
7. Behar D., Rapoport J.L., Berg C.J., Denckla M.B., Mann L., Cox C., Fedio P., Zahn I., Wolfman M.G. Computerized tomography and neuropsychological test measure in adolescents with obsessive-compulsive disorders. Am. J. Psychiatry. 141:1984;363-368.
8. Buscaino V.M., Balbi R. Fenomeni umorali nelle principali sindromi nevrosiche. Loro significato. Acta Neurol. 7:1952;401-442.
9. Clomipramine Collaborative Study Group Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry. 48:1991;730-738.
10. Destee A., Gray F., Parent M., Neuville V., Muller J.P., Verier A., Warot P. Comportement compulsif d'allure obsessionnelle et paralysie supranucléaire progressive. Rev. Neurol. 146:1990;12-18.
11. Foa, E.B., Kozak, M.J., 1994. DSM-IV and ICD-10 diagnostic criteria for obsessive compulsive disorder: similarity and differencies. In: Hollander, E., Zohar, J., Marazziti, D., OLiver, B. (Eds.), Current Insights in Obsessive Compulsive Disorder. John Wiley & Sons Ltd., Chichester, pp. 67-75.
12. Flor-Henry P., Yeudall L.T., Koles Z.J., Howarth B.G. Neuropsychological and power spectral EEG investigations of the obsessive-compulsive syndrome. Biol. Psychiatry. 24:1979;119-129.
13. Furlow, T.W.J., Hallenback, J.H., Goodman, J.E., 1980. Adrenergie blocking agents modify the auditory-evoked response in the rat. Brain Res. 189, 269-273.
14. Hegerl U., Lipperheide K., Juckel G., Schimidt L.G., Rommelspacher H. Antisocial tendencies and cortical sensory-evoked responses in alcoholism. Alcohol Clin. Exp. Res. 19:1995;31-36.
15. Hoffmeyer, O., Maurer, K., 1987. Zur Relevanz der frühen akustisch evozierten Potentiale (FAEP) und der visuell evozierten Potentiale (VEP) bei kinder- und jugendpsychiatrischen Patienten. In: Beckmann H., Laus, G. (Eds.), Biologische Psychiatrie. Springer-Verlag, Berlin, pp. 324-326.
16. Insel T.R., Mueller E.A., Alterman I., Linnoila M., Murphy D.L. Obsessive-compulsive disorder and serotonin: is there a connection? Biol. Psychiatry. 20:1985;1174-1188.
17. Kemali D., Vacca L., Marciano F., Nolfe G., Iorio G. CEEG findings in schizophrenics, depressive, obsessive, heroin addicts and normals. Adv. Biol. Psychiatry. 6:1981;17-28.
18. Khanna, S., Mukundan, C.R., Channabasavanna, S.M., 1989. Frontal lobes involvement in obsessive compulsive disorder. Electroecephalographic evidence. In: Lerer, B., Gershon, S. (Eds.), New Directions in Affective Disorders. Springer-Verlag, New York, pp. 154-158.
19. Kuskowski M.A., Malone S.M., Kim S.W., Dysken M.W., Okaya A.J., Christensen K.J. Quantitative EEG in obsessive-compulsive disorder. Biol. Psychiatry. 33:1993;423-430.
20. Laplane D., Levasseur M., Pillon B., Dubois B., Baulac M., Mazoyer B., Tran Dinh S., Sette G., Danze F., Baron J.C. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. Brain. 112:1989;699-725.
21. Lowitzsch, K., Maurer, K., Hopf, H.C., Tackmann, W., Claus, D., 1993. Evozierte potentiale bei erwachsenen und kindern Vep, Erg, Baep, P300, Sep, Mep. Georg Thieme Verlag, Stuttgart.
22. Luxenberg J.S., Swedo S.E., Flamen M.F. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computer tomography. Am. J. Psychiatry. 145:1988;1089-1093.
23. Markand O.N. Brainstem auditory evoked potentials. J. Clin. Neurphysiol. 11:1994;319-342.
24. Murphy D.L., Zohar J., Benkelfat C., Pato M.T., Pigot T.A., Insel T.R. Obsessive-compulsive disorder as a 5-HT subset system-related behavioural disorder. Br. J. Psychiatry. 8(Suppl.):1989;15-24.
25. Nieuwenhuys, R., Voogd, J., van Huijzen, Chr., 1988. The Human Central Nervous System. Springer-Verlag, Berlin.
26. Nordahl T.E., Benkelfat C., Semple W.E., Gross M., King A.C., Cohen R.M. Cerebral glucose metabolic rates in obsessive compulsive disorders. Neuropsychopharmacology. 2:1989;23-28.
27. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C.R., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen, Psychiatry. 51:1994;62-70.
28. Stuss, D.T., Benson, D.F., 1986. The Frontal Lobes. Raven Press, New York.
29. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry. 46:1989;518-523.
30. Talairach J., Bancaud S., Geier S. The cingulate gyrus and human behavior. Electroencephalogr. Clin. Neurophysiol. 34:1973;45-52.
31. Thoren P., Asberg M., Cronholm B., Jornestedt L., Traskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch. Gen. Psychiatry. 37:1980;1281-1285.
32. Thoren P., Asberg M., Bertilsson L., Mellstrom B., Sjsqvist F., Traskman L. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Arch. Gen. Psychiatry. 37:1980;1289-1294.
33. Towey J.P., Tenke C.E., Bruder G.E., Leite P., Friedman D., Liebowitz M., Hollander E. Brain event-related potential correlates of overfocused attention in obsessi-compulsive disorder. Pshychophysiology. 31:1994;535-543.
34. Volavka J., Neziroglu F., Yaryura-Tobias J.A. Clomipramine and imipramine in obsessive compulsive disorder. Psychiatry Res. 14:1985;83-92.
35. Zohar J., Insel T.R. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol. Psychiatry. 22:1987;667-687.
36. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch. Gen. Psychiatry. 44:1987;946-951.